Vanguard Group Inc Maia Biotechnology, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.34MCall Options Held
0Put Options Held
0-
Halter Ferguson Financial Inc. Carmel, IN241KShares$452,7370.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$371,3450.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$147,6190.0% of portfolio
-
Centric Wealth Management68.2KShares$128,2510.04% of portfolio
-
State Street Corp Boston, MA53.3KShares$100,1100.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...